Autoimmune diseases Medicines Approved in the EU (EMA)

• 111medicines authorised in the EU (authorised now)

Each number has its full source under its own list below.

• 18Sep2026

  Icotyde

  Active substance: icotrokinra hydrochloride

  EMEA/H/C/006730
• 19Jun2026

  Cenrifki

  Active substance: tolebrutinib

  EMEA/H/C/006386
• 27Apr2026

  Tuyory

  EMEA/H/C/006416
• 23Apr2026

  Fubelv

  EMEA/H/C/006738
• 10Feb2026

  Gotenfia

  Active substance: golimumab

  EMEA/H/C/006621
• 17Nov2025

  Gobivaz

  Active substance: golimumab

  EMEA/H/C/006560
• 17Nov2025

  Usgena

  Active substance: ustekinumab

  EMEA/H/C/006667
• 17Sep2025

  Usrenty

  Active substance: ustekinumab

  EMEA/H/C/006794
• 14Aug2025

  Usymro

  Active substance: ustekinumab

  EMEA/H/C/006467
• 28Jul2025

  Riulvy

  Active substance: tegomil fumarate

  EMEA/H/C/006427
• 14Feb2025

  Avtozma

  Active substance: tocilizumab

  EMEA/H/C/006196
• 14Feb2025

  Yesintek

  Active substance: ustekinumab

  EMEA/H/C/006444
• 12Dec2024

  Imuldosa

  Active substance: ustekinumab

  EMEA/H/C/006221
• 25Sep2024

  Otulfi

  Active substance: ustekinumab

  EMEA/H/C/006544
• 25Sep2024

  Fymskina

  Active substance: ustekinumab

  EMEA/H/C/005805

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

• Biologics and biosimilars
• Bones and joints
• Gut health
• Brain and nerves
• Skin and hair
• Kidney health